Yaakov Zarachia, 10% Owner at Wize Pharma, Inc. (WIZP), bought 5,000 shares at $0.12 ($600) on 2018-01-18, disclosed to the SEC on 2018-01-22.
Open-market purchase of $600 WIZP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| WIZP | BUY | 2018-01-08 | $676 | — | Filing → |
| WIZP | BUY | 2018-01-02 | $3K | — | Filing → |